Precigen (PGEN) Equity Income (2013 - 2025)

Precigen (PGEN) reported Equity Income of -$111.5 million for Q3 2025, down 2600.04% quarter-over-quarter from $4.5 million in Q2 2025.

Precigen (PGEN) Equity Income (2013 - 2025) Analysis & Trends

Precigen (PGEN) has 11 years of Equity Income data on file, last reported at -$111.5 million in Q3 2025.

  • Equity Income for Q3 2025 came in at -$111.5 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$107.0 million (down 229.55% YoY), and the FY2025 annual result was -$139.5 million, changed N/A from the prior year.
  • Equity Income fell to -$111.5 million in Q3 2025 per PGEN's latest filing, from $4.5 million in the prior quarter.
  • Over five years, Equity Income peaked at $4.5 million in Q2 2025 and troughed at -$111.5 million in Q3 2025.
  • A 3-year average of -$19.8 million and a median of -$1000.0 in 2022 frame the typical range for Equity Income.
  • The sharpest annual moves came in 2021 and 2022: Equity Income jumped 99.23% in 2021, then jumped 66.67% in 2022.
  • A 3-year view of Equity Income shows it stood at -$3000.0 in 2021, then surged by 133.33% to $1000.0 in 2022, then sank by 11150300.0% to -$111.5 million in 2025.
  • Business Quant data shows PGEN's Equity Income at -$111.5 million in Q3 2025, $4.5 million in Q2 2025, and -$32.5 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 235,807.00
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 Precigen 1.27 Bn 1.27 Bn 20.69 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -111.50 Mn
Jun 30, 2025 4.46 Mn
Mar 31, 2025 -32.48 Mn
Dec 31, 2022 1,000.00
Sep 30, 2022 862,000.00
Mar 31, 2022 -1,000.00
Mar 31, 2021 -3,000.00
Dec 31, 2020 -13,000.00
Sep 30, 2020 -523,000.00
Jun 30, 2020 -251,000.00
Mar 31, 2020 -389,000.00
Dec 31, 2019 -1.70 Mn
Sep 30, 2019 -479,000.00
Jun 30, 2019 -716,000.00
Mar 31, 2019 -1.64 Mn
Dec 31, 2018 -1.73 Mn
Sep 30, 2018 -2.87 Mn
Jun 30, 2018 -4.55 Mn
Mar 31, 2018 -2.46 Mn
Dec 31, 2017 -3.01 Mn